Epidemiology and Genomics Research
CANCER EPIDEMIOLOGY MATTERS E-NEWS
NOVEMBER 2017

Follow us on Twitter
November 2017 Features
Announcements
Contact Us
FOAsFunding
 Opportunity Announcements
RFA-CA-17-032 (U54) 
Minority Patient-Derived Xenograft (PDX) Development and Trial Centers
Applications Due: January 18, 2018
Expiration Date: January 19, 2018  

PAR-18-310  (UH3)
PAR-18-317  (UH2/UH3)
Assay Validation of High Quality Markers for Clinical Studies in Cancer
Applications Due: February 14, 2018; July 10, 2018; October 8, 2018; February 13, 2019; July 10, 2019; October 8, 2019; February 13, 2020; July 10, 2020; October 8, 2020
Expiration Date: October 9, 2020

PAR-18-021
 (NCI Omnibus R03)
NCI Small Grants Program for Cancer Research
Applications Due: February 27, 2018; June 29, 2018; October 26, 2018; February 26, 2019; June 28, 2019; October 25, 2019
Expiration Date: January 8, 2020

RFA-CA-18-002 (R21)
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Applications Due: February 28, 2018; May 29, 2018; September 28, 2018
Expiration Date: September 29, 2018
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Applications Due: February 28, 2018; May 29, 2018; September 28, 2018
Expiration Date: September 29, 2018

RFA-CA-18-004
 (R21)
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research
Applications Due: February 28, 2018; May 29, 2018; September 28, 2018
Expiration Date: September 29, 2018
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research
Applications Due: February 28, 2018; May 29, 2018; September 28, 2018
Expiration Date: September 29, 2018

PAR-17-496  (R01) 
Intervention Research to Improve Native American Health 
Applications Due: May 14, 2018; May 14, 2019; May 14, 2020
Expiration Date: May 15, 2020

PA-18-001
 (R01)
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research 
Applications Due: Standard Dates Apply
Expiration Date: May 18, 2018

PA-18-003 (R01) 
PA-18-013  (R21) 
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity 
Applications Due: Standard Dates Apply
Expiration Date: January 8, 2019

PA-18-385 (R01)
PA-18-406 (R21)
PA-18-407 (R21)
Population Health Interventions: Integrating Individual and Group Level Evidence
Applications Due: Standard Dates Apply
Expiration Date: May 8, 2019

PAR-18-352 (R01)
PAR-18-378 (R21)
Methodology and Measurement in the Behavioral and Social Sciences
Applications Due:  Standard Dates Apply
Expiration Date: September 8, 2019
 
PAR-18-366 (K22)
PAR-18-367
(K22)
NCI Transition Career Development Award to Promote Diversity
Applications Due: Standard Dates Apply
Expiration Date: January 8, 2021

PA-18-372
(Parent K08)

PA-18-373
(Parent K08)
Mentored Clinical Scientist Research Career Development Award
Applications Due: Standard Dates Apply
Expiration Date: January 8, 2021

PA-18-403 (Parent T32)
PA-18-404 (Parent T35)
Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant
Applications Due: Standard Dates Apply
Expiration Date: January 8, 2021
PolicyGrants Policy Announcements
NIH Will Make the Project Outcomes Section of all Interim and Final RPPRs Submitted on or After October 1, 2017 Available via the NIH RePORTER

NOT-OD-18-013
2018 NIH Regional Seminar on Program Funding & Grants Administration - Early Registration Rates Available Now
Early registration rates end December 15, 2017
RFIRequests  for
Informatio n
Information Resources on Lifestyle and Behavioral Factors Contributing to the Effectiveness of Cancer Therapies
Deadline: December 15, 2017
EventsUpcoming Webinars & Workshops
Conference on the Science of Dissemination and Implementation in Health
December 4-6, 2017
Arlington, VA

NIH Pathways to Prevention Workshop: Methods for Evaluating Natural Experiments in Obesity
December 5-6, 2017
Bethesda, MD

Improving Health Research on Small Populations: A Workshop
January 18-19, 2018
Washington, DC
BlogsBlog Posts
Dr. Mike Lauer
Open Mike Blog

Assuming the Role of NCI Director: Working to Accelerate Progress
Dr. Norman E. Sharpless
Cancer Currents Blog

Continuing Steps to Ensuring Credibility of NIH Research: Selecting Journals with Credible Practices
Dr. Mike Lauer
Open Mike Blog
AboutAbout EGRP
The Epidemiology and Genomics Research Program (EGRP) in the Division of Cancer Control and Population Sciences (DCCPS) funds research in human populations to understand the causes of cancer and related outcomes.

The Program fosters interdisciplinary collaborations, as well as the development and use of resources and technologies to advance cancer research and translation of this research, which serve as the basis for clinical and public health interventions.
ContactContact Us
email: nciepimatters@mail.nih.gov
website: epi.grants.cancer.gov
twitter: twitter.com/NCIEpi
Feature1Practical Resources for Managing NIH Grants

Participants at the 2017 DCCPS New Grantee Workshop

The Division of Cancer Control and Population Sciences (DCCPS) within the National Cancer Institute (NCI) hosted a workshop in September 2017 to assist investigators who have recently received R01 grants for the first time. While the presentations developed for this workshop were directed at new investigators, they will be useful to any grantee as s/he navigates the NIH grant system. They cover a wide range of topics and are listed below:
  • Role of the Program Director and Grant Specialist will help grantees understand who the key players are in the grants process, the program's perspective on managing an R01, and what role the program director and grants management specialist play at different stages of the grant. 
  • Successfully Managing Your R01 offers a general approach to managing a study and discusses some of the pertinent details of the practical aspects of grants management, such as budgeting, organizing the research environment, staffing, and managing the research team.
  • Fellowship and Training Grants addresses who should apply for training grants and when, describes where DCCPS disciplines fit into the competition for such grants, and provides an overview of NCI funding opportunities to increase diversity in cancer research.
  • Dissemination and Implementation seeks to define what Implementation Science is, discusses the current progress NIH has reached in this field, and shares the opportunities and resources available for those interested.
The Epidemiology and Genomics Research Program (EGRP) in DCCPS has additional grantsmanship resources, or you may contact our staff with any questions.

Feature2

Did You Know_ Changing NIH Human Subjects Research Policies May Impact Your Study

The NIH definition of a clinical trial is very broad and some investigators may not be aware that NIH considers their study to be a clinical trial. Identifying whether NIH considers your study to be a clinical trial is crucial because it impacts whether you will need to respond to clinical trial-specific funding opportunity announcements (FOAs), address additional review criteria specific for clinical trials, and register and report your trial in ClinicalTrials.gov.

The following questions serve as a guide for assessing whether NIH considers your human subjects research to be a clinical trial. Does your study
  • Involve one or more human subjects?
  • Prospectively assign human subjects to interventions?
  • Evaluate the effect of interventions on the human subjects?
  • Have a health-related biomedical or behavioral outcome
If you answered "yes" to all of these questions, your study is considered a clinical trial. If you aren't sure how to answer these questions, NIH has an online tool that can help at https://grants.nih.gov/ct-decision/index.htm.

The NIH definition of a clinical trial encompasses a wide range of study types.

For all application due dates on/after January 25, 2018, NIH is implementing new forms to collect human subjects information, use of a single Institutional Review Board for multi-site studies, and certificates of confidentiality for all research that uses "identifiable, sensitive information" to enhance the stewardship of research involving human subjects. NCI will publish Institute-specific Parent Project Grant (Parent R01 Clinical Trial Required) FOAs by January 2018 for investigator-initiated R01 applications that include a clinical trial.

For questions related to grant applications, please contact program directors in EGRP. View our staff list at https://epi.grants.cancer.gov/staff.

Feature3Learn More About EGRP's Upcoming Webinars!




December 11, 2017
2:00 p.m. to 3:00 p.m. ET

Dr. Meredith Shiels
Meredith Shiels, PhD, MHS

Investigator
Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute




January 17, 2018
2:00 p.m. to 3:00 p.m. ET 



Robin Vanderpool, DrPH, CHES

Associate Professor, Department of Health Behavior & Society, University of Kentucky





April 11, 2018
1:00 p.m. to 2:00 p.m. ET 



Emily Wang, MD, MAS

Associate Professor, Yale School of Medicine

Co-founder, Transitions Clinic Network


Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute | 9609 Medical Center Drive | 4 East, MSC 9763 | Bethesda | MD 20892

 
The Epidemiology and Genomics Research Program is a part of the National Cancer Institute's
 
 
NIH... Turning Discovery Into Health®